Learning objectives: I also want you to work & learn in a small peer group.
Thus, as described in deliverables, I want you to hand in an individually-created ontology, and then meet in groups of three students to build a "best" consensus solution ontology.
It is wise as a Chem 202 waitlister to go to a discussion just in case the only available section is a Chem 200 section.
Note: Please print or have on you the first discussion sheet: Discussion Sheet 1 Welcome to Chem 200 & 202 Fall 2019 Semester!!!
This 45 piece set includes 34 owls, 2 1/2" x 3";10 owl in moon pieces, 8 1/4" x 5 1/2"; and one header, 20 1/4" x 5 1/2".
Colorful Owls are ready to help teachers expand contemporary decorative themes into their curriculum!
In detail, here's what I'd like you to try: Finally, a few words about oncology: The primary difference between N2 and N3 is contralateral versus ipsalateral nodal metastases -- i.e. Please interprete the above to mean: Metastases to ipsalateral nodes. Although he's obviously French, I assume that's where the British spelling of "tumour" came from...
whether the involved node is in the same lung (ipsalateral) or in the opposite lung (contralateral) from the primary tumor. (Basically, I think that all uses of the word "and" in this AJCC sentence are misleading.) Credit goes to Olivier Dameron, now a professor in medical informatics at Renne University in France, and OWL guru, for creating the original TNM ontology. As noted on the Module 3 page, a good reference material for OWL is Matt Horridge's OWL tutorial for Protege4. An individual essay that describes the differences between the team-based ontology and your individual version (deliverable #1).
Your grade will be a combination of the individual work and the peer work. To make this assignment more practical, I have provided a starter ontology that has most of the structure and classes you will need to accomplish this task.
(Without this, there are too many possible ways of solving the problem! As a disclaimer, this task is completely toy -- an experienced oncologist would not need or use any sort of automatic decision support tool to determine cancer stage, given T, N and M infomation.